| Literature DB >> 30300140 |
Tae Hyun Kim1, Yoon Mee Yang1,2, Chang Yeob Han1,3, Ja Hyun Koo1, Hyunhee Oh4, Su Sung Kim4, Byoung Hoon You5, Young Hee Choi5, Tae-Sik Park6, Chang Ho Lee7, Hitoshi Kurose8, Mazen Noureddin9, Ekihiro Seki2, Yu-Jui Yvonne Wan10, Cheol Soo Choi4,11, Sang Geon Kim1.
Abstract
Nonalcoholic fatty liver disease (NAFLD) arises from mitochondrial dysfunction under sustained imbalance between energy intake and expenditure, but the underlying mechanisms controlling mitochondrial respiration have not been entirely understood. Heterotrimeric G proteins converge with activated GPCRs to modulate cell-signaling pathways to maintain metabolic homeostasis. Here, we investigated the regulatory role of G protein α12 (Gα12) on hepatic lipid metabolism and whole-body energy expenditure in mice. Fasting increased Gα12 levels in mouse liver. Gα12 ablation markedly augmented fasting-induced hepatic fat accumulation. cDNA microarray analysis from Gna12-KO liver revealed that the Gα12-signaling pathway regulated sirtuin 1 (SIRT1) and PPARα, which are responsible for mitochondrial respiration. Defective induction of SIRT1 upon fasting was observed in the liver of Gna12-KO mice, which was reversed by lentivirus-mediated Gα12 overexpression in hepatocytes. Mechanistically, Gα12 stabilized SIRT1 protein through transcriptional induction of ubiquitin-specific peptidase 22 (USP22) via HIF-1α increase. Gα12 levels were markedly diminished in liver biopsies from NAFLD patients. Consistently, Gna12-KO mice fed a high-fat diet displayed greater susceptibility to diet-induced liver steatosis and obesity due to decrease in energy expenditure. Our results demonstrate that Gα12 regulates SIRT1-dependent mitochondrial respiration through HIF-1α-dependent USP22 induction, identifying Gα12 as an upstream molecule that contributes to the regulation of mitochondrial energy expenditure.Entities:
Keywords: Fatty acid oxidation; G-proteins; Hepatology; Metabolism; Obesity
Mesh:
Substances:
Year: 2018 PMID: 30300140 PMCID: PMC6264648 DOI: 10.1172/JCI97831
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808